Literature DB >> 27380469

Reining in the supersized Phase I cancer trial.

Asher Mullard.   

Abstract

Entities:  

Year:  2016        PMID： 27380469     DOI： 10.1038/nrd.2016.129

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

1.  Reining in the supersized Phase I cancer trial.

Authors:  Asher Mullard
Journal:  Nat Rev Drug Discov       Date:  2016-06-01       Impact factor: 84.694
  1 in total
  1 in total

1.  Avelumab: clinical trial innovation and collaboration to advance anti-PD-L1 immunotherapy.

Authors:  K Chin; V K Chand; D S A Nuyten
Journal:  Ann Oncol       Date:  2017-07-01       Impact factor: 32.976
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.